Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.

@article{Emslie2007VenlafaxineEF,
  title={Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.},
  author={G. Emslie and R. Findling and P. Yeung and N. R. Kunz and Y. Li},
  journal={Journal of the American Academy of Child and Adolescent Psychiatry},
  year={2007},
  volume={46 4},
  pages={
          479-88
        }
}
  • G. Emslie, R. Findling, +2 authors Y. Li
  • Published 2007
  • Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
  • OBJECTIVE The safety, efficacy, and tolerability of venlafaxine extended release (ER) in subjects ages 7 to 17 years with major depressive disorder were evaluated in two multicenter, randomized, double-blind, placebo-controlled trials conducted between October 1997 and August 2001. METHOD Participants received venlafaxine ER (flexible dose, based on body weight; intent to treat, n = 169) or placebo (intent to treat, n = 165) for up to 8 weeks. The primary efficacy variable was the change from… CONTINUE READING
    98 Citations

    Topics from this paper.

    Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
    • 10
    • PDF
    Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder
    • 8
    • PDF
    Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.
    • 196
    • Highly Influenced
    • PDF
    Efficacy of antidepressants in juvenile depression: meta-analysis.
    • 136
    • PDF
    Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact.
    • 43
    Time-lag bias in trials of pediatric antidepressants: a systematic review and meta-analysis.
    • 19

    References

    SHOWING 1-10 OF 28 REFERENCES
    Venlafaxine in the treatment of children and adolescents with major depression.
    • 130
    Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
    • 68
    A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    • 908
    Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
    • 505
    • PDF
    Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment-resistant" major depression.
    • 119
    Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
    • 575
    • PDF
    Suicidality in pediatric patients treated with antidepressant drugs.
    • 878
    • Highly Influential
    • PDF